pBEVY-GA
(Plasmid
#51227)
-
Purpose(Empty Backbone) bi-directional expression vector for yeast, galactose inducible, ADE2 selection
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 51227 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepBEVY-GT
-
Backbone manufacturerAddgene plasmid 51231
-
Modifications to backbonepBEVY-GA was made by cutting pBEVY-GT with AatII and XcmI to remove the TRP1 gene. A fragment containing the ADE2 gene derived from a BglII digest of the pASZ11 plasmid was inserted using blunt ligation to generate pBEVY-GA.
-
Vector typeYeast Expression
- Promoter GAL1,10
-
Selectable markersADE2
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Cloning Information
- Cloning method Restriction Enzyme
- 5′ sequencing primer Gal1 and Gal10Pro_F (Common Sequencing Primers)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
Depositor Comments
Please note that there are minor discrepancies between Addgene's quality control sequence and depositor's reference sequence. The changes are in cloning junctions and should not affect plasmid function.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pBEVY-GA was a gift from Charles Miller (Addgene plasmid # 51227 ; http://n2t.net/addgene:51227 ; RRID:Addgene_51227) -
For your References section:
Assessment of aryl hydrocarbon receptor complex interactions using pBEVY plasmids: expressionvectors with bi-directional promoters for use in Saccharomyces cerevisiae. Miller CA 3rd, Martinat MA, Hyman LE. Nucleic Acids Res. 1998 Aug 1;26(15):3577-83. 10.1093/nar/26.15.3577 PubMed 9671822